Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 2
1962 2
1964 2
1965 2
1966 3
1967 2
1968 3
1969 2
1970 2
1971 3
1972 3
1973 5
1974 6
1975 7
1976 7
1977 4
1978 7
1979 5
1980 6
1981 7
1982 10
1983 4
1984 4
1985 5
1986 11
1987 7
1988 6
1989 7
1990 4
1991 9
1992 3
1993 5
1994 4
1995 2
1996 3
1997 4
1998 2
1999 7
2000 4
2001 8
2002 4
2003 5
2004 4
2005 3
2006 7
2007 10
2008 8
2009 8
2010 6
2011 7
2012 6
2013 3
2014 3
2015 6
2016 4
2017 6
2018 7
2019 2
2020 9
2021 6
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F; PROFILE 1014 Investigators. Solomon BJ, et al. N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440. N Engl J Med. 2014. PMID: 25470694 Free article. Clinical Trial.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Home environment questionnaire.
Sines JO, Clarke WM, Lauer RM. Sines JO, et al. Among authors: lauer rm. J Abnorm Child Psychol. 1984 Dec;12(4):519-29. doi: 10.1007/BF00916847. J Abnorm Child Psychol. 1984. PMID: 6491059
Childhood predictors of high blood pressure.
Mahoney LT, Clarke WR, Burns TL, Lauer RM. Mahoney LT, et al. Among authors: lauer rm. Am J Hypertens. 1991 Nov;4(11):608S-610S. doi: 10.1093/ajh/4.11s.608s. Am J Hypertens. 1991. PMID: 1789940 Review.
Drug design strategies for the treatment of prostate cancer.
Lauer RC, Friend SC, Rietz C, Pasqualini R, Arap W. Lauer RC, et al. Expert Opin Drug Discov. 2015 Jan;10(1):81-90. doi: 10.1517/17460441.2015.978855. Epub 2014 Nov 4. Expert Opin Drug Discov. 2015. PMID: 25366417 Review.
297 results